XNCR FY 2012 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$883M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+39.1% YoY

Gross Profit

-$3M-33.0% margin

Operating Income

-$6M-65.4% margin

Net Income

-$9M-90.2% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$29,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$31M

Stockholders' Equity

-$20M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+39.1%
Gross Profit	-$3M	$7M	-145.9%
Operating Income	-$6M	-$9M	+34.1%
Net Income	-$9M	-$11M	+23.3%